Terms: = Lymphoma AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C
90 results:
1. [When EBV serology needs a blot to conclude: a case report].
Périllaud-Dubois C; Bouthry E; Kounis I; Roque-Afonso AM; Vauloup-Fellous C
Ann Biol Clin (Paris); 2022 Jul; 80(4):385-388. PubMed ID: 36099348
[TBL] [Abstract] [Full Text] [Related]
2. Impact of Epstein-Barr virus co-infection on natural acquired Plasmodium vivax antibody response.
Dias MHF; Guimarães LFF; Barcelos MG; Moreira EUM; do Nascimento MFA; de Souza TN; Pires CV; Monteiro TAF; Middeldorp JM; Soares IS; Fontes CJF; Ntumngia FB; Adams JH; Kano FS; Carvalho LH
PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010305. PubMed ID: 35921373
[TBL] [Abstract] [Full Text] [Related]
3. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
Stubbins RJ; Korotev S; Godley LA
Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
[TBL] [Abstract] [Full Text] [Related]
4. Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, Canada.
Bankar A; Zhao H; Iqbal J; Coxford R; Cheung MC; Mozessohn L; Earle CC; Gupta V
Leuk Lymphoma; 2020 Aug; 61(8):1908-1919. PubMed ID: 32323602
[TBL] [Abstract] [Full Text] [Related]
5. [Safety and efficacy of patients with refractory B-lymphoblastic leukemia treated with anti-CD19 CAR-T cell bridging to allogeneic hematopoietic stem cell transplantation].
Ai H; Yin QS; Wang Q; Fu YW; Wei XD; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):239-244. PubMed ID: 32311895
[No Abstract] [Full Text] [Related]
6. Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis.
Varma A; Sui D; Milton DR; Tang G; Saini N; Hasan O; Mukherjee A; Joseph JJ; Bashir Q; Rondon G; Srour S; Popat UR; Hosing CM; Nieto Y; Kebriaei P; Alousi AM; Ahmed S; Mehta R; Khouri IF; Ahmed H; Iyer S; Weber DM; Thomas SK; Manasanch E; Lee HC; Patel K; Ciurea SO; Shpall EJ; Orlowski RZ; Champlin RE; Qazilbash MH
Biol Blood Marrow Transplant; 2020 Apr; 26(4):665-671. PubMed ID: 31881283
[TBL] [Abstract] [Full Text] [Related]
7. The potential health gain and cost savings of improving adherence in chronic myeloid leukemia.
Ector GICG; Govers TM; Westerweel PE; Grutters JPC; Blijlevens NMA
Leuk Lymphoma; 2019 Jun; 60(6):1485-1492. PubMed ID: 30668187
[TBL] [Abstract] [Full Text] [Related]
8. Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin lymphoma.
Halec G; Waterboer T; Brenner N; Butt J; Hardy WD; DʼSouza G; Wolinsky S; Macatangay BJ; Pawlita M; Detels R; Martínez-Maza O; Hussain SK
J Acquir Immune Defic Syndr; 2019 Mar; 80(3):e53-e63. PubMed ID: 30531297
[TBL] [Abstract] [Full Text] [Related]
9. SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through cdkn2c Repression.
Lin CH; Wong SH; Kurzer JH; Schneidawind C; Wei MC; Duque-Afonso J; Jeong J; Feng X; Cleary ML
Cell Rep; 2018 Apr; 23(4):1166-1177. PubMed ID: 29694893
[TBL] [Abstract] [Full Text] [Related]
10. Response to the treatment immediately before nivolumab monotherapy may predict clinical response to nivolumab in patients with non-small cell lung cancer.
Kobayashi H; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi T
Int J Clin Oncol; 2017 Aug; 22(4):690-697. PubMed ID: 28382561
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical analysis of laryngeal non-Hodgkin's lymphoma].
Chen L; Zhang M; Li C; Zhou L; Zhu JX; Pang SY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(7):546-548. PubMed ID: 29871307
[No Abstract] [Full Text] [Related]
12. Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation.
Xie Y; Pittaluga S; Price S; Raffeld M; Hahn J; Jaffe ES; Rao VK; Maric I
Haematologica; 2017 Feb; 102(2):364-372. PubMed ID: 27846610
[TBL] [Abstract] [Full Text] [Related]
13. Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders.
Sarkozy C; Kaltenbach S; Faurie P; Canioni D; Berger F; Traverse-Glehen A; Ghesquieres H; Salles G; Bachy E; Alyanakian MA; Hermine O; Neven B; Macintyre E; Romana S; Molina TJ; Suarez F; Asnafi V; Bruneau J
Genes Chromosomes Cancer; 2017 Mar; 56(3):221-230. PubMed ID: 27750397
[TBL] [Abstract] [Full Text] [Related]
14. A multicenter study on the utility and safety of EBUS-TBNA and EUS-B-FNA in children.
Dhooria S; Madan K; Pattabhiraman V; Sehgal IS; Mehta R; Vishwanath G; Srinivasan A; Sivaramakrishnan M; Mohan A; Mathew JL; Kabra SK; Guleria R; Behera D; Agarwal R
Pediatr Pulmonol; 2016 Oct; 51(10):1031-1039. PubMed ID: 27142997
[TBL] [Abstract] [Full Text] [Related]
15. ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm.
Marchetti A; Di Lorito A; Pace MV; Iezzi M; Felicioni L; D'Antuono T; Filice G; Guetti L; Mucilli F; Buttitta F
J Thorac Oncol; 2016 Apr; 11(4):487-95. PubMed ID: 26916631
[TBL] [Abstract] [Full Text] [Related]
16. Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia.
Yeh CH; Bai XT; Moles R; Ratner L; Waldmann TA; Watanabe T; Nicot C
Mol Cancer; 2016 Feb; 15():15. PubMed ID: 26880370
[TBL] [Abstract] [Full Text] [Related]
17. Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT.
Sellner L; Boumendil A; Finel H; Choquet S; de Rosa G; Falzetti F; Scime R; Kobbe G; Ferrara F; Delmer A; Sayer H; Amorim S; Bouabdallah R; Finke J; Salles G; Yakoub-Agha I; Faber E; Nicolas-Virelizier E; Facchini L; Vallisa D; Zuffa E; Sureda A; Dreger P;
Bone Marrow Transplant; 2016 Feb; 51(2):212-218. PubMed ID: 26569093
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic factors for survival of patients with newly diagnosed chronic GVHD according to NIH criteria.
Ayuk F; Veit R; Zabelina T; Bussmann L; Christopeit M; Alchalby H; Wolschke C; Lellek H; Bacher U; Zander AR; Kröger N
Ann Hematol; 2015 Oct; 94(10):1727-32. PubMed ID: 26204824
[TBL] [Abstract] [Full Text] [Related]
19. Epstein-Barr virus and risk of non-Hodgkin lymphoma in the cancer prevention study-II and a meta-analysis of serologic studies.
Teras LR; Rollison DE; Pawlita M; Michel A; Brozy J; de Sanjose S; Blase JL; Gapstur SM
Int J Cancer; 2015 Jan; 136(1):108-16. PubMed ID: 24831943
[TBL] [Abstract] [Full Text] [Related]
20. Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target.
Demeure MJ; Aziz M; Rosenberg R; Gurley SD; Bussey KJ; Carpten JD
World J Surg; 2014 Jun; 38(6):1296-305. PubMed ID: 24633422
[TBL] [Abstract] [Full Text] [Related]
[Next]